SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Apr 10, 2013
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: April 10, 2013 · CIK: 0001433607 · Accession: 0001144204-13-021043
AI Filing Summary & Sentiment
File numbers found in text: 333-184066
Show Raw Text
CORRESP
1
filename1.htm
April
10, 2013
U.S.
Securities and Exchange Commission
100
F. Street, NE
Washington,
D.C. 20549
Re:
InspireMD, Inc.
Registration Statement on
Form S-1
Filed September 24, 2012
File No. 333-184066
VIA
FACSIMILE
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Cowen and Company, LLC, as representative of the underwriters, hereby requests acceleration of the effective date
of the above-referenced Registration Statement so that it will become effective at 4:30 p.m., Washington D.C. time, on April 10,
2013, or as soon thereafter as practicable.
The
following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:
(i) Date
of preliminary prospectus: April 9, 2013
(ii) Dates
of distribution: The preliminary prospectus dated April 9, 2013 was distributed from April 9, 2013 to April 10, 2013.
(iii) Number
of prospective underwriters and dealers to whom preliminary prospectuses were furnished: 2
(iv) Number
of prospectuses so distributed: 150
The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.
COWEN
AND COMPANY, LLC
By:
/s/
Jason Fenton
Name:
Jason Fenton
Title:
Managing Director